Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

NIH Grant Aims to Make Drugs Taste Better, Not Bitter

Dispensing pills

A new award from National Institutes of Health funds a study to identify components in taste bud cells that block bitter taste sensations encountered in some drugs and foods. . . . → Read More: NIH Grant Aims to Make Drugs Taste Better, Not Bitter

Clinical Trial Testing Anti-Resistant Malaria Therapy

Malaria clinic

A clinical trial is getting underway that tests the safety and dosage levels of a new drug to treat malaria and block resistance from developing to it. . . . → Read More: Clinical Trial Testing Anti-Resistant Malaria Therapy

Genomic Sequencing for Newborns Studied in Clinical Trial

Newborn

A group of newborn infants with genetic disorders that went undetected in standard testing will receive genomic sequencing in a clinical study of its safety and feasibility. . . . → Read More: Genomic Sequencing for Newborns Studied in Clinical Trial

Peptide Pain Drugs in Development Aimed at Alternative Targets

Neuron

Pain drugs made from peptides, small protein-like compounds, and guided by antibodies are being developed as alternatives to prescription opioids to treat moderate to severe pain. . . . → Read More: Peptide Pain Drugs in Development Aimed at Alternative Targets

Cancer Drug Delivery Through Milk Particles Under Study

Cattle

A new research project is investigating components in raw cow’s milk that could make it possible to give chemotherapy for cancer as oral drugs rather than infusions. . . . → Read More: Cancer Drug Delivery Through Milk Particles Under Study

Engineered Bacteria Studied for Rare Inherited Skin Disorder

f Staphylococcus epidermidis

A biotechnology company and research lab are evaluating a modified skin bacteria as a treatment for Netherton syndrome, a rare inherited skin disease affecting mainly infants and young children. . . . → Read More: Engineered Bacteria Studied for Rare Inherited Skin Disorder

NIH Small Business Grant Funds Severe Hepatitis Treatment

RNA strand illustration

A biotechnology company is developing treatments for a severe form of hepatitis, which up to now has only limited therapy options, with a synthetic form of RNA designed to shut down the infecting virus. . . . → Read More: NIH Small Business Grant Funds Severe Hepatitis Treatment

Experimental Drug Extends Survival, Reverses Inherited ALS Damage

ALS patient in clinical trial

An experimental drug designed to silence a protein associated with inherited forms of amyotrophic lateral sclerosis, or ALS, is shown in tests with lab rodents to extend survival and reverse some neuromuscular damage. . . . → Read More: Experimental Drug Extends Survival, Reverses Inherited ALS Damage

NIH Grant Funds New Spinal Cord Injury Treatment

Spine

A biotechnology company developing regenerative therapies for neurological disorders is receiving a Small Business Innovation Research grant to advance an experimental treatment for spinal cord injury. . . . → Read More: NIH Grant Funds New Spinal Cord Injury Treatment

Engineered Polio Virus Tested as Brain Cancer Treatment

Brain tumor graphic

Results of a clinical trial show a genetically engineered polio virus helps more people with glioblastoma, an aggressive form of brain cancer, survive for longer periods. . . . → Read More: Engineered Polio Virus Tested as Brain Cancer Treatment